Summary

Japan Pharmacy Benefit Management Services Market Research Report By Service Type (Claims Management, Formulary Management, Drug Utilization Review, Medication Therapy Management), By End User (Pharmacies, Health Plans, Employers, Public Sector), By Service Provider (Standalone Pharmacy Benefit Managers, Health Insurance Companies, Integrated Health Systems) and By Operating Model (Fully-Managed Services, Pass-Through Services, Hybrid Services) - Growth & Industry Forecast 2025 To 2035

Market Summary:
As per Market Research Future analysis, the Japan pharmacy benefit-management services market size was estimated at 26.58 USD Billion in 2024. The Japan pharmacy benefit-management-services market is projected to grow from 28.68 USD Billion in 2025 to 61.25 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.8% during the forecast period 2025 - 2035

Market Drivers:
Japan's demographic shift towards an aging population is a crucial driver for the pharmacy benefit-management-services market. With over 28% of the population aged 65 and older, the demand for prescription medications is surging. Older adults typically require multiple medications, leading to complex medication management needs. This demographic trend necessitates the implementation of pharmacy benefit-management services to ensure appropriate medication use, adherence, and cost control. In 2025, it is projected that the number of elderly individuals requiring chronic disease management will increase, further emphasizing the need for effective pharmacy benefit strategies. Consequently, the pharmacy benefit-management-services market is likely to expand as healthcare providers and insurers seek to address the unique challenges posed by this demographic. Regulatory changes in Japan are shaping the landscape of the pharmacy benefit-management-services market. Recent reforms aimed at controlling drug prices and enhancing transparency in pharmaceutical transactions are influencing how pharmacy benefits are structured. The government has implemented measures to encourage the use of generic medications, which can lead to cost savings for both patients and insurers.

Market Segment Analysis:
The Japan Pharmacy Benefit Management Services Market is poised for considerable growth, driven by a variety of service types that cater to the healthcare needs of the population. This market encompasses several critical areas, including Claims Management, Formulary Management, Drug Utilization Review, and Medication Therapy Management, which together form the backbone of effective pharmacy benefit services. Claims Management is pivotal in ensuring that reimbursements for medication costs are processed efficiently and accurately, which ultimately enhances trust between patients, pharmacies, and insurers. Furthermore, Formulary Management plays a significant role in defining the list of covered medications optimizing cost-effectiveness while maintaining patient access to necessary treatments. The careful evaluation within Drug Utilization Review is crucial for identifying potential issues such as drug interactions and overprescribing, which in turn supports patient safety and encourages rational drug use.

Regional Analysis:
The pharmacy benefit-management-services market is currently experiencing notable transformations, driven by various factors including technological advancements and evolving healthcare policies. In Japan, the integration of digital health solutions is becoming increasingly prevalent, as stakeholders seek to enhance the efficiency of medication management and improve patient outcomes. This shift appears to be influenced by a growing emphasis on personalized medicine, which necessitates tailored approaches to pharmacy benefits. Furthermore, the collaboration between healthcare providers and pharmacy benefit managers is likely to strengthen, fostering a more cohesive healthcare ecosystem that prioritizes patient-centric care. Additionally, regulatory changes are shaping the landscape of the pharmacy benefit-management-services market.

Major Players:
The following companies are key participants in the Japan Pharmacy Benefit Management Services Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT
1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation
3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
Japan Pharmacy Benefit Management Services Market Segmentation
Japan Pharmacy Benefit Management Services Market By Service Type (USD Billion, 2019-2035)
Claims Management
Formulary Management
Drug Utilization Review
Medication Therapy Management
Japan Pharmacy Benefit Management Services Market By End User (USD Billion, 2019-2035)
Pharmacies
Health Plans
Employers
Public Sector
Japan Pharmacy Benefit Management Services Market By Service Provider (USD Billion, 2019-2035)
Standalone Pharmacy Benefit Managers
Health Insurance Companies
Integrated Health Systems
Japan Pharmacy Benefit Management Services Market By Operating Model (USD Billion, 2019-2035)
Fully-Managed Services
Pass-Through Services
Hybrid Services
Japan Pharmacy Benefit Management Services Market By Regional (USD Billion, 2019-2035)
North America
Europe
South America
Asia Pacific
Middle East and Africa
Japan Pharmacy Benefit Management Services Market SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the pharmacy benefit-management services market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the pharmacy benefit-management services market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Mitsui Sumitom
Insurance Group
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Nippon Life Insurance Company
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Dai-ichi Life Holdings, Inc.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Aflac Life Insurance Japan Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
SOMPO Holdings, Inc.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Toki
Marine Holdings, Inc.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mitsubishi UFJ Trust and Banking Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Asahi Mutual Life Insurance Company
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

COMPANIES MENTIONED
Mitsui Sumitomo Insurance Group, Nippon Life Insurance Company, Dai-ichi Life Holdings, Inc., Aflac Life Insurance Japan Ltd., SOMPO Holdings, Inc., Tokio Marine Holdings, Inc., Mitsubishi UFJ Trust and Banking Corporation, Asahi Mutual Life Insurance Company

ページTOPに戻る

List of Tables/Graphs

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET ANALYSIS BY TYPE
FIGURE 3 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET ANALYSIS BY END USER
FIGURE 4 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET ANALYSIS BY SERVICE PROVIDER
FIGURE 5 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET ANALYSIS BY OPERATING MODEL
FIGURE 6 KEY BUYING CRITERIA OF PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET
FIGURE 7 RESEARCH PROCESS OF MRFR
FIGURE 8 DRO ANALYSIS OF JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET
FIGURE 9 DRIVERS IMPACT ANALYSIS: JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET
FIGURE 10 RESTRAINTS IMPACT ANALYSIS: JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET
FIGURE 11 SUPPLY / VALUE CHAIN: JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET
FIGURE 12 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 13 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY TYPE, 2024 TO 2035 (USD Billion)
FIGURE 14 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY END USER, 2024 (% SHARE)
FIGURE 15 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY END USER, 2024 TO 2035 (USD Billion)
FIGURE 16 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY SERVICE PROVIDER, 2024 (% SHARE)
FIGURE 17 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY SERVICE PROVIDER, 2024 TO 2035 (USD Billion)
FIGURE 18 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY OPERATING MODEL, 2024 (% SHARE)
FIGURE 19 JAPAN PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET, BY OPERATING MODEL, 2024 TO 2035 (USD Billion)
FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan PHARMACY BENEFIT-MANAGEMENT SERVICES MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY TYPE, 2026-2035 (USD Billion)
TABLE 2 BY TYPE, 2026-2035 (USD Billion)
TABLE 3 BY END USER, 2026-2035 (USD Billion)
TABLE 4 BY END USER, 2026-2035 (USD Billion)
TABLE 5 BY SERVICE PROVIDER, 2026-2035 (USD Billion)
TABLE 6 BY SERVICE PROVIDER, 2026-2035 (USD Billion)
TABLE 7 BY OPERATING MODEL, 2026-2035 (USD Billion)
TABLE 8 BY OPERATING MODEL, 2026-2035 (USD Billion)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP